Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G.
Banno H, et al. Among authors: yamada s.
Ann Neurol. 2009 Feb;65(2):140-50. doi: 10.1002/ana.21540.
Ann Neurol. 2009.
PMID: 19259967
Clinical Trial.